Grs Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 20.04%
(FY 2023)
- Profit 44.74%
(FY 2023)
- Ebitda 56.88%
(FY 2023)
- Net Worth 13.11%
(FY 2023)
- Total Assets 10.69%
(FY 2023)
About Grs Pharmaceuticals
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Ashtamkar and Nilesh Mehta serve as directors at the Company.
- CIN/LLPIN
U24110MH2009PTC194699
- Company No.
194699
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Grs Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Ashtamkar  | Director | 04-Mar-2023 | Current |
Nilesh Mehta  | Director | 24-Mar-2011 | Current |
Financial Performance of Grs Pharmaceuticals.
Grs Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.04% increase. The company also saw a substantial improvement in profitability, with a 44.74% increase in profit. The company's net worth Soared by an impressive increase of 13.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grs Pharmaceuticals?
In 2022, Grs Pharmaceuticals had a promoter holding of 99.98% and a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Grs Pharmaceuticals?
Unlock and access historical data on people associated with Grs Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grs Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
